Drug details

Vowst (fecal microbiota spores, live-brpk capsules)

type of Gastrointestinal Agents, Other

Vowst (fecal microbiota spores, live-brpk) contains live bacterial spores and is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI).

This drug may have the following side effects:

• constipation,
• fatigue,
• diarrhea.
• chills, and
• abdominal distension/bloating,

The following drugs are related to Vowst, either as a replacement or used together:

• Dificid (fidaxomicin tablets for oral administration)
• Firvanq (vancomycin hydrochloride for oral solution)
• Flagyl (metronidazole)
• Flagyl ER (metronidazole extended release tablets)
• Pfizerpen (penicillin g potassium)